Registration is now open for part 2 of the medication webinar. So many people asked us to have Dr. Fraimow complete his talk that we asked him back, and added content about 3HP. Patty Woods will also present a 3HP case study and discuss current recommendations for administration of 3HP.

Consider forwarding this to your clinical colleagues, who may be interested in providing 3HP therapy (or other LTBI therapy) as they begin to screen and test for LTBI.

Any difficulties with the registration, please contact me. The Register button in the flyer is active; otherwise go to

From: The National TB Controllers Association <ntca@tbcontrollers.org>
Sent: Thursday, October 4, 2018 11:18 AM
To: Lorna Will
Subject: Registration Open for October 17 Webinar on Adverse Effects of LTBI Medications

Managing Adverse Effects

from TB Medications: Part 2

Details

This webinar is co-sponsored by the National TB Nurse Coalition (NTNC), a section of the National TB Controllers Association (NTCA).

This webinar is part of a series put together by the NTNC, the Curry International TB Center (CITC), the Global TB Institute (GTBI), the Heartland National TB Center (HNTC), and the Southeastern National TB Center (SNTC).

Agenda:

Includes a special section on management of 3HP treatment for LTBI

Cost:

NTCA Members: Free

Nonmembers: $20

Credits:

1 CEU for Nurses

Registration is required. To register now, click below.